PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead ...

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

After all those holiday indulgences, many people feel the need to hit the “reset” button with a detox or cleanse for a ...

Investing.com -- CG Oncology Inc (NASDAQ:CGON) stock surged 18.1% on Friday after the company announced it expects to deliver topline data from its Phase 3 PIVOT-006 clinical trial nearly a year ahead ...

Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...

When the doctor finally arrived and okayed the removal of the catheter, my penis proceeded to emit a three-second fart, ...

Fortunately, eight days after surgery, I received the pathology report and was elated to read that it was an oncocytoma ...